Cargando...
Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD
Vascular endothelial growth factor (VEGF) is a key mediator in the development and progression of choroidal neovascularization (CNV) in patients with wet age-related macular degeneration (AMD). As a consequence, current treatment strategies typically focus on the administration of anti-VEGF agents,...
Gardado en:
| Publicado en: | Sci Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Nature Publishing Group UK
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6079038/ https://ncbi.nlm.nih.gov/pubmed/30082848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-29726-7 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|